Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program
Transfusion · 2023
DOI: 10.1111/trf.17331 ↗At a glance
Journal article in Transfusion, 2023. Written by John C Myers and 20 co-authors. Institution: Department of Surgery, UT Health San Antonio, San Antonio, Texas, USA. Major MEDLINE topics: Postpartum Hemorrhage, Placenta Accreta. Cited 4 times so far (Crossref); 14 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Postpartum hemorrhage (PPH) is one of the leading causes of obstetric complications. The goal of this study was to identify risk factors for obstetric (OB) massive transfusion (MT) and determine the feasibility of developing a low‐titer group O RhD‐positive whole blood (LTO + WB) protocol for OB hemorrhage. Study Design and Methods A retrospective study of OB patients who received transfusion within 24 h. MT patients were those who received >3 U of pRBC within 1 h or > 10 U in 24 h. Patient demographics, OB history, comorbidities, blood type, antibody status, and known risk factors for PPH and maternal‐fetal outcomes were compared. Logistic regression was used for univariate and multivariate analyses.
Results
Of the 610 transfused OB patients, 12.0% ( n = 73) required MT. Groups were well matched for body mass index (BMI), maternal comorbidities, and history of spontaneous vaginal deliveries. The incidence of the previous cesarean section was higher in the MT group. Exactly 93.9% of patients were RhD‐positive and 3.77% of all patients possessed an antibody on pretransfusion testing. Patients with MT had a longer length of stay (LOS), higher rate of intensive care unit (ICU) admission, fetal death, and hysterectomy. Multivariate analysis found age >35, PPH, placenta percreta, accreta, and increta to be significant ( p < .05) risk factors for MT.
Discussion
Patients over 35 years and those with abnormal placentation are at increased risk of requiring MT. With a time to delivery of 2 days, potential MT patients can be identified early, and with a 94% rate of RhD‐positive+, they are eligible to receive low‐titer O whole blood (LTOWB) providing hemostatic resuscitation with reduced donor exposure.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Surgery, UT Health San Antonio, San Antonio, Texas, USA.
- Department of Pathology, UT Health San Antonio, San Antonio, Texas, USA.
- Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, Texas, USA.
- Department of Urology, UT Health San Antonio, San Antonio, Texas, USA.
- Department of Anesthesia, UT Health San Antonio, San Antonio, Texas, USA.
- Military Health Institute, UT Health San Antonio, San Antonio, Texas, USA.
ORCID profiles: John C Myers, Maxwell A Braverman, Angelo Ciaraglia
Cite
APA
Myers, J. C., Braverman, M. A., Ciaraglia, A., Alkhateb, R., Barry, L., Brooke, Z., Chang, J., Wang, H., Elenes, R., Hepburn, B., Ireland, K., Jonas, R., Nelson, J., Pedraza, S., Song, J., Nicholson, S., Eastridge, B., Stewart, R., Greebon, L., …, & Jenkins, D. (2023). Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program. Transfusion. https://doi.org/10.1111/trf.17331
Vancouver
Myers JC, Braverman MA, Ciaraglia A, Alkhateb R, Barry L, Brooke Z, et al. Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program. Transfusion. 2023. doi:10.1111/trf.17331
BibTeX
@article{Myers2023,
author = {Myers, John C and Braverman, Maxwell A and Ciaraglia, Angelo and Alkhateb, Rahaf and Barry, Lauran and Brooke, Zachary and Chang, Jeffrey and Wang, Hanzhang and Elenes, Rafael and Hepburn, Byron and Ireland, Kayla and Jonas, Rachelle and Nelson, Jeremy and Pedraza, Santiago and Song, Jun and Nicholson, Susannah and Eastridge, Brian and Stewart, Ronald and Greebon, Leslie and Xenakis, Elly and Jenkins, Donald},
title = {Risk factors for massive transfusion in obstetrical hemorrhage and consideration of a whole blood program},
journal = {Transfusion},
year = {2023},
doi = {10.1111/trf.17331}
}
EUVIMED